CRDF — Cardiff Oncology Share News
0.000.00%
Last trade - 00:00- $70.58m
- $34.93m
- $0.59m
Cardiff Oncology jumps on equity investment from Pfizer
Brief: Cardiff Oncology Announces $15 Million Equity Investment From Pfizer Through Its Pfizer Breakthrough Growth Initiative
Brief: Cardiff Oncology Posts Quarterly Loss Per Share Of $0.17
Cardiff Oncology Inc reports results for the quarter ended in September - Earnings Summary
Cardiff Oncology Inc expected to post a loss of 17 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Twist Bioscience, Box, Support.com
U.S. STOCKS ON THE MOVE-Gevo, Peloton, Quest Diagnostics
U.S. STOCKS ON THE MOVE-Moderna, Beauty Health, Boston Beer
U.S. STOCKS ON THE MOVE-GameStop, Google, Humanigen
Cardiff Oncology jumps on new colorectal cancer therapy data
Brief: Cardiff Oncology Announces Data From Phase 1B/2 Trial In Colorectal Cancer
Brief: Cardiff Oncology To Present New Data From Lead Clinical Program In KRAS-Mutated Metastatic Colorectal Cancer On September 8, 2021
Brief: Cardiff Oncology Reports Qtrly Loss Per Share $0.17
Cardiff Oncology Inc reports results for the quarter ended in June - Earnings Summary
Cardiff Oncology Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Cardiff Oncology Added To The Russell 2000 And Other FTSE Russell Indexes
U.S. STOCKS ON THE MOVE-Target, Wendy's, Hyatt Hotels, Sage, crypto stocks
Cardiff Oncology: Rises on starting mid-stage trial of pancreatic cancer treatment
Brief: Cardiff Oncology Announces First Patient Dosed In A Phase 2 Trial Of Onvansertib In Combination With Irinotecan And 5-Fu In Pancreatic Cancer